GILD
Gilead Sciences, Inc.
NASDAQ · Healthcare · Drug Manufacturers - General · US
$151.00
−0.15%Margins
Gross margin
79.6%
EBITDA margin
2.1%
EBIT margin
-4.9%
Net margin
-10.6%
FCF margin
43.3%
-27.4%
Return on equity
-6.6%
Return on assets
-3.9%
Return on invested capital
0.58x
Asset turnover
$13.6B
Cash from operations
$2.56
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026